TD2 to Present Precision Preclinical Applications for Glioblastoma and Non-Small Cell Lung Cancer at AACR Annual Meeting
Three Poster Presentations Highlight Novel Data SCOTTSDALE, ARIZONA, UNITED STATES, April 3, 2024 /EINPresswire.com/ -- Translational Drug Development (TD2), a precision oncology contract research organization (CRO), announces the presentation of their …